AB
ALT icon

Amalgamated Bank’s Altimmune ALT Stock Holding History

Amalgamated Bank’s Portfolio ALT Stock Details ALT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-2,786
Closed -$10K – 1666
2025
Q4 		$10K Buy
2,786
+335
+14% +$1.46K ﹤0.01% 2404
2025
Q3 		$9K Hold
2,451
– – ﹤0.01% 2496
2025
Q2 		$9K Hold
2,451
– – ﹤0.01% 2458
2025
Q1 		$12K Buy
2,451
+784
+47% +$4.97K ﹤0.01% 2266
2024
Q4 		$12K Hold
1,667
– – ﹤0.01% 2331
2024
Q3 		$10K Hold
1,667
– – ﹤0.01% 2433
2024
Q2 		$11K Hold
1,667
– – ﹤0.01% 2374
2024
Q1 		$17K Sell
1,667
-2,645
-61% -$26.9K ﹤0.01% 2186
2023
Q4 		$49K Sell
4,312
-496
-10% -$2.07K ﹤0.01% 2255
2023
Q3 		$13K Hold
4,808
– – ﹤0.01% 2828
2023
Q2 		$17K Buy
+4,808
New +$21.6K ﹤0.01% 2806
2022
Q2 		– Sell
-4,793
Closed -$29K – 3032
2022
Q1 		$29K Buy
+4,793
New +$35.3K ﹤0.01% 2690

Other funds holding ALT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Amalgamated Bank's ALT Position: Q1 2026 in Review

Amalgamated Bank sold out of Altimmune (ALT) in Q1 2026, closing a stake of 2,786 shares — an estimated $10K sold.

Amalgamated Bank first reported a position in ALT in Q1 2022 and held it in 12 quarters. The position peaked at $49K in Q4 2023. 173 funds tracked by Wall St. Rank hold ALT as of Q1 2026.

  • Amalgamated Bank reported no remaining Altimmune position as of Q1 2026 after selling out during the quarter.
  • Amalgamated Bank sold 2,786 Altimmune shares in Q1 2026, an estimated $10K.
  • Amalgamated Bank first reported a position in Altimmune in Q1 2022 and held it in 12 quarters.
  • Amalgamated Bank's Altimmune position peaked at $49K in Q4 2023.
  • 173 funds tracked by Wall St. Rank held Altimmune as of Q1 2026.

Based on Amalgamated Bank's 13F filing for Q1 2026, filed 8 May 2026.